Intellia Therapeutics On March 19, Notified Regeneron Pharmaceuticals That Co Is Opting Out Of Its Factor IX Co-Development And Co-Funding Agreement
Intellia Therapeutics On March 19, Notified Regeneron Pharmaceuticals That Co Is Opting Out Of Its Factor IX Co-Development And Co-Funding Agreement
Intellia Therapeutics於3月19日通知Regeneron Pharmicals，該公司選擇退出其Factor IX共同開發和聯合資助協議
Intellia Therapeutics On March 19, Notified Regeneron Pharmaceuticals That Co Is Opting Out Of Its Factor IX Co-Development And Co-Funding Agreement
Intellia Therapeutics於3月19日通知Regeneron Pharmicals，該公司選擇退出其Factor IX共同開發和聯合資助協議
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。